Purchase Order 12405B19P0494
- Not listed
- The U.S. government awarded a $78,336 firm fixed-price purchase order to Illumina, Inc. on September 26, 2019, for genomic sequencing consumables. The contract, issued by a civilian federal agency's Northeast Area office, requires delivery of a BeadChip ABT 6000 Infinium HD i-Select-24 kit (catalog number WG-401-1001) capable of processing 48 samples with 3072-90K resolution to Illumina's San Diego, California facility by October 26, 2019. The procurement did not utilize a set-aside designation,...
- Illumina, Inc., a San Diego-based biotechnology company specializing in genomic sequencing and analysis technologies, was awarded a Purchase Order contract by the Office of Administrative Services Procurement Management Branch on April 7, 2015, with a ceiling value of $29,529.80 and an ultimate completion date of April 30, 2016. This Firm Fixed Price contract, which carries no set-aside designation, is to be performed in Athens, Georgia. As a leading provider of DNA and RNA sequencing...
- The U.S. government awarded a delivery order valued at $490,365.19 to Illumina, Inc. for the procurement of various laboratory supplies and genomic sequencing consumables, including NexteraXT sample preparation kits, MiSeq V2 cartridges, MiSeq reagent kits, and NexteraXT V2 reagents. The award was issued on June 8, 2021, with an ultimate completion date of October 19, 2021, under a Firm Fixed Price contract structure with no set-aside designation. Performance was to occur in St. Louis, Missouri,...
- This is a firm fixed-price purchase order awarded by a civilian federal agency to Illumina, Inc., a for-profit manufacturer of genetic sequencing technologies. The $47,945.52 contract is for kitted reagents to prepare DNA sequencing libraries and complete four instrument runs using Illumina's HiSeq2000 DNA sequencer, generating 200 base pairs of sequence data per molecule. The award is not associated with a set-aside designation or a larger federal contract vehicle. Illumina has been awarded...
- Illumina, Inc. was awarded a purchase order by a civilian federal agency for genomic sequencing reagents and consumables valued at $23,623.39. The contract, awarded on December 17, 2018, with an ultimate completion date of December 26, 2018, procures five specific product lines including TruSeq DNA Single Indexes Sets A and B, TruSeq DNA PCR-Free Low Throughput Library Prep Kit, NextSeq 500/550 High Output Kit v2.5, and MiSeq Reagent Kit v2. These products represent core components of Illumina's...
- The U.S. government awarded a $17,971.20 firm fixed-price purchase order to Illumina, Inc. for an Infinium HD Select-24 Kit containing 48 samples and 2 custom BeadChips. The contract was executed on August 15, 2018, with an ultimate completion date of September 14, 2018, and performance conducted at Illumina's San Diego, California location. No set-aside designation was applied to this award, reflecting the specialized nature of the genomic sequencing technology being procured. The funding...
- This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract, valued at $20,400.00, is for the provision of ILLUMINA - AMPLISEQ products and services, with a period of performance through September 30, 2024. The contract has no set-aside designation. Illumina has a history of providing sequencing equipment and consumables to support...
- On September 12, 2018, the Southeast Area civilian federal agency awarded a $17,971.20 firm fixed-price purchase order to Illumina, Inc. for the Infinium HD Select-24 Kit (Catalog Number WG-401-1001). The contract was completed by October 11, 2018, with no set-aside designation applied. Illumina, a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies, served as the sole prime contractor on this order, with performance taking place at its...
- The U.S. government awarded a delivery order contract valued at approximately $95,931 to Illumina, Inc. for the procurement of a MiSeq System, a DNA and RNA sequencing instrument used for genomic analysis and research applications. Illumina, a biotechnology company headquartered in San Diego, California, specializes in advanced sequencing technologies and related products including reagents, consumables, and bioinformatics software. This contract was awarded on August 4, 2021, by a civilian...
- This is a $19,812.90 firm fixed-price purchase order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and related products. The contract has an ultimate completion date of August 3, 2026 and was awarded on August 4, 2025. No set-aside designation was used. Illumina, a leading provider of DNA and RNA sequencing technologies, will deliver a range...
This purchase order, awarded on September 24, 2019, to Illumina, Inc., a leading biotechnology company specializing in genetic sequencing and genomic analysis technologies, provides laboratory supplies totaling $16,954.50. The contract deliverables include TruSeq and NextSeq kits, which are advanced reagent systems used for DNA and RNA sequencing applications. The contract is a firm fixed-price purchase order with no set-aside designation, reflecting Illumina's specialized technological capabilities in genomic sequencing. The work is to be completed by October 23, 2019, and will be performed at Illumina's location in San Diego, California. The awarding agency is a civilian federal entity operating under the Southeast Area designation. This contract represents a routine procurement of consumable laboratory supplies from Illumina, a vendor that maintains extensive contract relationships across multiple federal agencies including the National Institutes of Health, Centers for Disease Control and Prevention, Department of Agriculture, Department of Veterans Affairs, and Food and Drug Administration. Illumina's sequencing kits and instruments serve critical functions in scientific research, healthcare diagnostics, and environmental monitoring initiatives across the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.0k | 9/25/19 |